{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:32:18Z","timestamp":1774949538729,"version":"3.50.1"},"reference-count":101,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>HIV latency, driven by a complex interplay of host factors, remains a key barrier to viral clearance. Current latency-reversing agents (LRAs) demonstrate limited efficacy and specificity, and none have been approved for clinical use. Although natural products have shown promise as LRAs, the therapeutic potential of fungal metabolites remains underexplored. Candida albicans, a prevalent human commensal and opportunistic pathogen, produces diverse secondary metabolites that can influence host pathways, affecting latency dynamics. This study aimed to investigate the latency-modulating potential of secondary metabolites of C. albicans using an integrative network pharmacology and computational pipeline. C. albicans secondary metabolites were retrieved from the literature, screened for drug-likeness, and mapped to human targets and biological pathways annotated in HIV latency. Key metabolites, hub genes, and pathways were systematically characterized through network and computational analyses. Six drug-like candidates, identified from 185 absorption, distribution, metabolism, excretion, and toxicity (ADMET)-screened metabolites, collectively mapped to 369 human genes with a 6.5% overlap in HIV latency (176 shared and 20 hub genes). These overlapping genes were significantly enriched for signal transduction, membrane localization, and adaptive responses to chemical stimuli. Kyoto encyclopedia of genes and genomes (KEGG) enrichment revealed oncogenic diseases (non-small cell lung, pancreatic, and prostate cancers) and latency-associated cascades, including PD-L1\/PD-1, HIF-1, Ras, PI3K-Akt, calcium, and cAMP signaling. Six hub targets (MAPK1, PIK3CA, MAPK3, EGFR, MTOR, and AKT1) were consistently annotated within the top 30 KEGG pathways and displayed strong binding affinities for MET 15 and MET 119. Molecular dynamics (MD) simulations confirmed favorable binding free energies (BFEs) and stable conformational dynamics for the top-ranked metabolite MET 15. C. albicans secondary metabolites preferentially target oncogenic signaling networks central to HIV latency maintenance, notably PI3K\/AKT\/MTOR and MAPK\/ERK, which regulate cell survival, metabolic homeostasis, and viral transcriptional repression. MET 15 is a top-ranked candidate metabolite for HIV latency-reversing therapeutics and warrants experimental validation in established latency models.<\/jats:p>","DOI":"10.3390\/ijms27073125","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:41:03Z","timestamp":1774878063000},"page":"3125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Network Pharmacology-Guided Identification of Candida albicans Secondary Metabolites as Modulators of HIV Latency via Oncogenic Signaling Pathways"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7325-6635","authenticated-orcid":false,"given":"Ernest","family":"Oduro-Kwateng","sequence":"first","affiliation":[{"name":"HIV Pathogenesis Programme, School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4013, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugochukwu J.","family":"Anyaneji","sequence":"additional","affiliation":[{"name":"HIV Pathogenesis Programme, School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4013, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asiphe","family":"Fanele","sequence":"additional","affiliation":[{"name":"HIV Pathogenesis Programme, School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4013, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntokozo","family":"Ntanzi","sequence":"additional","affiliation":[{"name":"HIV Pathogenesis Programme, School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4013, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud E.","family":"Soliman","sequence":"additional","affiliation":[{"name":"Molecular Bio-Computation and Drug Design Research Group, School of Health Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-9201","authenticated-orcid":false,"given":"Nompumelelo P.","family":"Mkhwanazi","sequence":"additional","affiliation":[{"name":"HIV Pathogenesis Programme, School of Laboratory Medicine and Medical Sciences, College of Health Science, University of KwaZulu-Natal, Durban 4013, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2055-6640(20)30275-2","article-title":"Establishment of Latent HIV-1 Reservoirs: What Do We Really Know?","volume":"5","author":"Vanhamel","year":"2019","journal-title":"J. Virus Erad."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100597","DOI":"10.1016\/j.jve.2025.100597","article-title":"HIV-1 Latency: From Acquaintance to Confidant","volume":"11","author":"Yang","year":"2025","journal-title":"J. Virus Erad."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mohammadzadeh, N., Chomont, N., Estaquier, J., Cohen, E.A., and Power, C. (2023). Is the Central Nervous System Reservoir a Hurdle for an HIV Cure?. Viruses, 15.","DOI":"10.20944\/preprints202311.0277.v1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-virology-091919-103029","article-title":"The Current Status of Latency Reversing Agents for HIV-1 Remission","volume":"8","author":"Rodari","year":"2021","journal-title":"Annu. Rev. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Vansant, G., Bruggemans, A., Janssens, J., and Debyser, Z. (2020). Block-and-Lock Strategies to Cure HIV Infection. Viruses, 12.","DOI":"10.3390\/v12010084"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113213","DOI":"10.1016\/j.ejmech.2021.113213","article-title":"HIV Latency Reversal Agents: A Potential Path for Functional Cure?","volume":"213","author":"Lopes","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Tioka, L., Diez, R.C., S\u00f6nnerborg, A., and van de Klundert, M.A.A. (2025). Latency Reversing Agents and the Road to a HIV Cure. Pathogens, 14.","DOI":"10.3390\/pathogens14030232"},{"key":"ref_8","unstructured":"Vaillant, A.A.J., and Naik, R. (2023). HIV-1\u2013Associated Opportunistic Infections, StatPearls."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nikou, S.A., Kichik, N., Brown, R., Ponde, N.O., Ho, J., Naglik, J.R., and Richardson, J.P. (2019). Candida albicans Interactions with Mucosal Surfaces during Health and Disease. Pathogens, 8.","DOI":"10.3390\/pathogens8020053"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/21505594.2021.2019950","article-title":"Pathogenesis and Virulence of Candida albicans","volume":"13","author":"Lopes","year":"2022","journal-title":"Virulence"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mib.2019.06.002","article-title":"Candidalysin: Discovery and Function in Candida albicans Infections","volume":"52","author":"Naglik","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e00143-15","DOI":"10.1128\/mBio.00143-15","article-title":"The Fungal Quorum-Sensing Molecule Farnesol Activates Innate Immune Cells but Suppresses Cellular Adaptive Immunity","volume":"6","author":"Leonhardt","year":"2015","journal-title":"mBio"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"eaba6617","DOI":"10.1126\/sciadv.aba6617","article-title":"Gliotoxin, Identified from a Screen of Fungal Metabolites, Disrupts 7SK SnRNP, Releases P-TEFb, and Reverses HIV-1 Latency","volume":"6","author":"Stoszko","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.febslet.2011.10.018","article-title":"The Suv39H1 Methyltransferase Inhibitor Chaetocin Causes Induction of Integrated HIV-1 without Producing a T Cell Response","volume":"585","author":"Bernhard","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13659-025-00572-1","article-title":"Harziachalasins A\u2013G, Polycyclic-Fused Cytochalasins from the Endophytic Fungus Trichoderma harzianum MLJ-4 with HIV Latency Reversal Activity","volume":"16","author":"Zhang","year":"2026","journal-title":"Nat. Prod. Bioprospect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/DDDT.S319786","article-title":"Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San against Ulcerative Colitis","volume":"15","author":"Liu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.2147\/DDDT.S265198","article-title":"Integrated Network Pharmacology Analysis and Experimental Validation to Reveal the Mechanism of Anti-Insulin Resistance Effects of Moringa Oleifera Seeds","volume":"14","author":"Huang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2147\/DDDT.S369832","article-title":"Study on the Mechanism of Improving HIV\/AIDS Immune Function with Jian Aikang Concentrated Pill Based on Network Pharmacology Combined with Experimental Validation","volume":"16","author":"Shao","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154103","DOI":"10.1016\/j.phymed.2022.154103","article-title":"Combined Multi-Omics and Network Pharmacology Approach Reveals the Role of Tripterygium wilfordii Hook F in Treating HIV Immunological Non-Responders","volume":"101","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Oduro-Kwateng, E., Abo-Dya, N.E., Soliman, M.E., and Mkhwanazi, N.P. (2025). Phytochemicals from Euclea natalensis Modulate Th17 Differentiation, HIV Latency, and Comorbid Pathways: A Systems Pharmacology and Thermodynamic Profiling Approach. Microorganisms, 13.","DOI":"10.3390\/microorganisms13092150"},{"key":"ref_21","first-page":"655","article-title":"Analysis of Bioactive Metabolites from Candida albicans Using (GC-MS) and Evaluation of Antibacterial Activity","volume":"8","author":"Kadhim","year":"2016","journal-title":"Int. J. Pharm. Clin. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.25258\/ijddt.13.1.42","article-title":"Bioactive Secondary Metabolites Extracted from Some Species of Candida Isolated from Women Infected with Vulvovaginal Candidiasis","volume":"13","author":"Hassan","year":"2023","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1038\/s41598-020-73889-1","article-title":"Metabolic Profiling of Candida Clinical Isolates of Different Species and Infection Sources","volume":"10","author":"Oliver","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Li, L., Liao, Z.B., Yang, Y., Lv, L., Cao, Y.Y., and Zhu, Z.Y. (2018). Metabolomic Profiling for the Identification of Potential Biomarkers Involved in a Laboratory Azole Resistance in Candida albicans. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192328"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Alhameed, R.A., Semreen, M.H., Hamad, M., Giddey, A.D., Sulaiman, A., Al Bataineh, M.T., Al-Hroub, H.M., Bustanji, Y., Alzoubi, K.H., and Soares, N.C. (2023). Multi-Omics Profiling of Candida albicans Grown on Solid Versus Liquid Media. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122831"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13543776.2020.1718653","article-title":"Pharmacological Applications of Farnesol (C15H26O): A Patent Review","volume":"30","author":"Delmondes","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2008.11.011","article-title":"Farnesol Promotes Epithelial Cell Defense against Candida albicans through Toll-like Receptor 2 Expression, Interleukin-6 and Human \u03b2-Defensin 2 Production","volume":"45","author":"Savignac","year":"2009","journal-title":"Cytokine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s10787-023-01413-8","article-title":"Neuroprotective Mechanism of Trans,Trans-Farnesol in an ICV-STZ-Induced Rat Model of Alzheimer\u2019s Pathology","volume":"32","author":"Kadian","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wen, J., Okyere, S.K., Wang, S., Wang, J., Xie, L., Ran, Y., and Hu, Y. (2022). Endophytic Fungi: An Effective Alternative Source of Plant-Derived Bioactive Compounds for Pharmacological Studies. J. Fungi, 8.","DOI":"10.3390\/jof8020205"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"827717","DOI":"10.3389\/fcimb.2022.827717","article-title":"CounterAKTing HIV: Toward a \u201cBlock and Clear\u201d Strategy?","volume":"12","author":"Pasquereau","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/22221751.2022.2026198","article-title":"Pharmacological Suppression of Glycogen Synthase Kinase-3 Reactivates HIV-1 from Latency via Activating Wnt\/\u03b2-Catenin\/TCF1 Axis in CD4+ T Cells","volume":"11","author":"Wen","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wee, P., and Wang, Z. (2017). Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. Cancers, 9.","DOI":"10.3390\/cancers9050052"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2025). The STAT Signaling Pathway in HIV-1 Infection: Roles and Dysregulation. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202508.2068.v1"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Khanal, S., Schank, M., El Gazzar, M., Moorman, J.P., and Yao, Z.Q. (2021). Hiv-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in Hiv Latency Studies. Cells, 10.","DOI":"10.3390\/cells10020475"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xu, X., Lin, Y., Zeng, X., Yang, C., Duan, S., Ding, L., Lu, W., Lin, J., Pan, X., and Ma, X. (2022). PARP1 Might Substitute HSF1 to Reactivate Latent HIV-1 by Binding to Heat Shock Element. Cells, 11.","DOI":"10.3390\/cells11152331"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bbrc.1999.1146","article-title":"Poly (ADP-Ribose) Polymerase Is Involved in PMA-Induced Activation of HIV-1 in U1 Cells by Modulating the LTR Function","volume":"262","author":"Kameoka","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"White, C.H., Moesker, B., Beliakova-Bethell, N., Martins, L.J., Spina, C.A., Margolis, D.M., Richman, D.D., Planelles, V., Bosque, A., and Woelk, C.H. (2016). Transcriptomic Analysis Implicates the P53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006026"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"a007096","DOI":"10.1101\/cshperspect.a007096","article-title":"HIV Latency","volume":"1","author":"Siliciano","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pasquereau, S., Kumar, A., and Herbein, G. (2017). Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: From Immune Activation to Viral Reservoirs. Viruses, 9.","DOI":"10.3390\/v9040064"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/QAD.0b013e3283081e08","article-title":"Peroxisome Proliferator-Activated Receptor-\u03b3 Activation Suppresses HIV-1 Replication in an Animal Model of Encephalitis","volume":"22","author":"Potula","year":"2008","journal-title":"AIDS"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E7795","DOI":"10.1073\/pnas.1803468115","article-title":"Estrogen Receptor-1 Is a Key Regulator of HIV-1 Latency That Imparts Gender-Specific Restrictions on the Latent Reservoir","volume":"115","author":"Das","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"107504","DOI":"10.1016\/j.celrep.2020.03.068","article-title":"Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via MTORC1","volume":"31","author":"Figlia","year":"2020","journal-title":"Cell Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mohammadi, P., di Iulio, J., Mu\u00f1oz, M., Martinez, R., Bartha, I., Cavassini, M., Thorball, C., Fellay, J., Beerenwinkel, N., and Ciuffi, A. (2014). Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004156"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s000180050106","article-title":"Oxidative Stress in Human Immunodeficiency Virus Infection","volume":"53","year":"1997","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2008.08.114","article-title":"Reactive Oxygen Species Activate HIV Long Terminal Repeat via Post-Translational Control of NF-\u039aB","volume":"376","author":"Pyo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874091X00701010012","article-title":"Lipid Rafts and Caveolae in Signaling by Growth Factor Receptors","volume":"1","author":"Donovan","year":"2007","journal-title":"Open Biochem. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/embo-reports\/kvd025","article-title":"Membrane Raft Microdomains Mediate Lateral Assemblies Required for HIV-1 Infection","volume":"1","author":"Lacalle","year":"2000","journal-title":"EMBO Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/JVI.73.4.3460-3466.1999","article-title":"Regulation of Human Immunodeficiency Virus Type 1 Infectivity by the ERK Mitogen-Activated Protein Kinase Signaling Pathway","volume":"73","author":"Yang","year":"1999","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.chom.2016.11.001","article-title":"The MTOR Complex Controls HIV Latency","volume":"20","author":"Besnard","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pagans, S., Pedal, A., North, B.J., Kaehlcke, K., Marshall, B.L., Dorr, A., Hetzer-Egger, C., Henklein, P., Frye, R., and McBurney, M.W. (2005). SIRT1 Regulates HIV Transcription via Tat Deacetylation. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030041"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1873-3468.14033","article-title":"AP-1 and NF-\u039aB Synergize to Transcriptionally Activate Latent HIV upon T-Cell Receptor Activation","volume":"595","author":"Hokello","year":"2021","journal-title":"FEBS Lett."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"van der Mescht, M.A., Steel, H.C., Anderson, R., and Rossouw, T.M. (2024). Vascular Endothelial Growth Factor A: Friend or Foe in the Pathogenesis of HIV and SARS-CoV-2 Infections?. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1458195"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Omar, A., Marques, N., and Crawford, N. (2024). Cancer and HIV: The Molecular Mechanisms of the Deadly Duo. Cancers, 16.","DOI":"10.3390\/cancers16030546"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12977-024-00639-w","article-title":"The Cell Biology of HIV-1 Latency and Rebound","volume":"21","author":"Mbonye","year":"2024","journal-title":"Retrovirology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2014.02.008","article-title":"Transcriptional Control of HIV Latency: Cellular Signaling Pathways, Epigenetics, Happenstance and the Hope for a Cure","volume":"454\u2013455","author":"Mbonye","year":"2014","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2019.03.014","article-title":"Mechanisms of HIV-1 Cell-to-Cell Transmission and the Establishment of the Latent Reservoir","volume":"265","author":"Pedro","year":"2019","journal-title":"Virus Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/QAD.0000000000001849","article-title":"Programmed Cell Death-1 Contributes to the Establishment and Maintenance of HIV-1 Latency","volume":"32","author":"Evans","year":"2018","journal-title":"AIDS"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 Blockade Potentiates HIV Latency Reversal Ex Vivo in CD4+ T Cells from ART-Suppressed Individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s42003-020-1103-1","article-title":"Hypoxic Microenvironment Shapes HIV-1 Replication and Latency","volume":"3","author":"Zhuang","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/1743-422X-8-477","article-title":"Regulation of the HIV-1 Promoter by HIF-1 and Vpr Proteins","volume":"8","author":"Deshmane","year":"2011","journal-title":"Virol. J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chan, J.K., Bhattacharyya, D., Lassen, K.G., Ruelas, D., and Greene, W.C. (2013). Calcium\/Calcineurin Synergizes with Prostratin to Promote NF-\u039aB Dependent Activation of Latent HIV. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077749"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.09.015","article-title":"Synergistic Reactivation of Latent HIV-1 Provirus by PKA Activator Dibutyryl-CAMP in Combination with an HDAC Inhibitor","volume":"227","author":"Lim","year":"2017","journal-title":"Virus Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular MicroRNAs Contribute to HIV-1 Latency in Resting Primary CD4+ T Lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/QAD.0000000000001649","article-title":"Reversing HIV Latency via Sphingosine-1-Phosphate Receptor 1 Signaling","volume":"31","author":"Duquenne","year":"2017","journal-title":"AIDS"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Resop, R.S., Fromentin, R., Newman, D., Rigsby, H., Dubrovsky, L., Bukrinsky, M., Chomont, N., and Bosque, A. (2020). Fingolimod Inhibits Multiple Stages of the HIV-1 Life Cycle. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008679"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Quinville, B.M., Deschenes, N.M., Ryckman, A.E., and Walia, J.S. (2021). A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115793"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Thomas, S., Samuel, S.V., Hoch, A., Syphurs, C., and Diray-Arce, J. (2023). The Implication of Sphingolipids in Viral Infections. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417303"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Avota, E., Bodem, J., Chithelen, J., Mandasari, P., Beyersdorf, N., and Schneider-Schaulies, J. (2021). The Manifold Roles of Sphingolipids in Viral Infections. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.715527"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/cb500870a","article-title":"Targeting Conformational Plasticity of Protein Kinases","volume":"10","author":"Tong","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hasan, G.M., Mohammad, T., Zaidi, S., Shamsi, A., and Hassan, M.I. (2025). Molecular Docking and Dynamics in Protein Serine\/Threonine Kinase Drug Discovery: Advances, Challenges, and Future Perspectives. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1696204"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Schaefer, M.H., Serrano, L., and Andrade-Navarro, M.A. (2015). Correcting for the Study Bias Associated with Protein\u2013Protein Interaction Measurements Reveals Differences between Protein Degree Distributions from Different Cancer Types. Front. Genet., 6.","DOI":"10.3389\/fgene.2015.00260"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkab1128","article-title":"ConsensusPathDB 2022: Molecular Interactions Update as a Resource for Network Biology","volume":"50","author":"Kamburov","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Soto-Acosta, R., Jung, E., Qiu, L., Wilson, D.J., Geraghty, R.J., and Chen, L. (2021). 4,7-Disubstituted 7H-Pyrrolo[2,3-d]Pyrimidines and Their Analogs as Antiviral Agents against Zika Virus. Molecules, 26.","DOI":"10.3390\/molecules26133779"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/med.21942","article-title":"Recent Progress and Structural Analyses of Domain-Selective BET Inhibitors","volume":"43","author":"Divakaran","year":"2023","journal-title":"Med. Res. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"113220","DOI":"10.1016\/j.ejmech.2021.113220","article-title":"Synthetic and Medicinal Perspective of Quinolines as Antiviral Agents","volume":"215","author":"Kaur","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"17279","DOI":"10.1039\/C8RA01216D","article-title":"Design, Synthesis, and Biological Evaluation of AV6 Derivatives as Novel Dual Reactivators of Latent HIV-1","volume":"8","author":"Ao","year":"2018","journal-title":"RSC Adv."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s11030-022-10387-8","article-title":"Therapeutic Potential of Pyrrole and Pyrrolidine Analogs: An Update","volume":"26","author":"Basavarajaiah","year":"2022","journal-title":"Mol. Divers."},{"key":"ref_78","first-page":"473","article-title":"Natural Products as Antiviral Agents","volume":"24","year":"2007","journal-title":"Stud. Nat. Prod. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/12051125","article-title":"Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity","volume":"12","author":"Oh","year":"2007","journal-title":"Molecules"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Nieto-Garai, J.A., Glass, B., Bunn, C., Giese, M., Jennings, G., Brankatschk, B., Agarwal, S., B\u00f6rner, K., Xabier Contreras, F., and Kn\u00f6lker, H.J. (2018). Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01983"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"117089","DOI":"10.1016\/j.biopha.2024.117089","article-title":"Roles of the Peroxisome Proliferator-Activated Receptors (PPARs) in the Pathogenesis of Hepatocellular Carcinoma (HCC)","volume":"177","author":"Pan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Jung, Y.Y., Hwang, S.T., Sethi, G., Fan, L., Arfuso, F., and Ahn, K.S. (2018). Potential Anti-Inflammatory and Anti-Cancer Properties of Farnesol. Molecules, 23.","DOI":"10.3390\/molecules23112827"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Nzimande, B., Kumalo, H.M., Ndlovu, S.I., and Mkhwanazi, N.P. (2022). Secondary Metabolites Produced by Endophytic Fungi, Alternaria Alternata, as Potential Inhibitors of the Human Immunodeficiency Virus. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.1077159"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Kharde, A.V., and Singh, D. (2024). Microbial Secondary Metabolites: As a Therapeutic Agents. Microbial Essentialism: An Industrial Prospective; Developments in Applied Microbiology and Biotechnology, Academic Press.","DOI":"10.1016\/B978-0-443-13932-1.00014-3"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: A Webserver for the Prediction of Toxicity of Chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: Updated Data and New Features for Efficient Prediction of Protein Targets of Small Molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Safran, M., Rosen, N., Twik, M., BarShir, R., Stein, T.I., Dahary, D., Fishilevich, S., and Lancet, D. (2022). The GeneCards Suite. Practical Guide to Life Science Databases, Springer.","DOI":"10.1007\/978-981-16-5812-9_2"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","article-title":"Cytoscape Automation: Empowering Workflow-Based Network Analysis","volume":"20","author":"Otasek","year":"2019","journal-title":"Genome Biol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Chin, C.H., Chen, S.H., Wu, H.H., Ho, C.W., Ko, M.T., and Lin, C.Y. (2014). CytoHubba: Identifying Hub Objects and Sub-Networks from Complex Interactome. BMC Syst. Biol., 8.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: A Graphical Gene-Set Enrichment Tool for Animals and Plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gky473","article-title":"CASTp 3.0: Computed Atlas of Surface Topography of Proteins","volume":"46","author":"Tian","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsb.2011.09.006","article-title":"UCSF Chimera, MODELLER, and IMP: An Integrated Modeling System","volume":"179","author":"Yang","year":"2012","journal-title":"J. Struct. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: Fully Automated Protein-Ligand Interaction Profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine Microsecond Molecular Dynamics Simulations with AMBER\u2014Part II: Particle Mesh Ewald","volume":"9","author":"Goetz","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s12013-024-01266-0","article-title":"Unveiling Therapeutic Frontiers: DON\/DRP-104 as Innovative Plasma Kallikrein Inhibitors against Carcinoma-Associated Hereditary Angioedema Shocks\u2014A Comprehensive Molecular Dynamics Exploration","volume":"82","author":"Soliman","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","article-title":"Assessing the Performance of MM\/PBSA and MM\/GBSA Methods. 7. Entropy Effects on the Performance of End-Point Binding Free Energy Calculation Approaches","volume":"20","author":"Sun","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: An Efficient Program for End-State Free Energy Calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s12013-025-01709-2","article-title":"Computational Analysis of Plasmodium Falciparum DNA Damage Inducible Protein 1 (PfDdi1): Insights into Binding of Artemisinin and Its Derivatives and Implications for Antimalarial Drug Design","volume":"83","author":"Kehinde","year":"2025","journal-title":"Cell Biochem. Biophys."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:38:12Z","timestamp":1774946292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":101,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073125"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073125","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}